Wells Trecaso Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.7M Sell
30,739
-22,147
-42% -$3.79M 2.71% 13
2025
Q2
$8.08M Buy
52,886
+175
+0.3% +$26.9K 2.49% 13
2025
Q1
$8.74M Buy
52,711
+1,259
+2% +$197K 2.92% 11
2024
Q4
$7.44M Buy
51,452
+167
+0.3% +$25.9K 2.43% 12
2024
Q3
$8.31M Buy
51,285
+201
+0.4% +$32K 2.73% 12
2024
Q2
$7.47M Buy
51,084
+450
+0.9% +$66.9K 2.58% 13
2024
Q1
$8.01M Buy
50,634
+1,835
+4% +$292K 2.83% 12
2023
Q4
$7.65M Buy
48,799
+419
+0.9% +$64.2K 3.08% 10
2023
Q3
$7.54M Buy
48,380
+551
+1% +$90.9K 3.35% 8
2023
Q2
$7.92M Buy
47,829
+436
+0.9% +$70.4K 3.41% 8
2023
Q1
$7.35M Buy
47,393
+815
+2% +$132K 3.4% 7
2022
Q4
$8.23M Buy
46,578
+364
+0.8% +$62.9K 4.11% 6
2022
Q3
$7.55M Buy
46,214
+331
+0.7% +$56K 4.14% 3
2022
Q2
$8.14M Sell
45,883
-186
-0.4% -$33.1K 4.22% 3
2022
Q1
$8.16M Buy
46,069
+1,003
+2% +$171K 3.64% 7
2021
Q4
$7.71M Buy
45,066
+601
+1% +$98.4K 3.35% 8
2021
Q3
$7.18M Buy
44,465
+269
+0.6% +$45.9K 3.42% 9
2021
Q2
$7.28M Buy
44,196
+610
+1% +$101K 3.5% 10
2021
Q1
$7.16M Buy
43,586
+85
+0.2% +$13.8K 3.78% 7
2020
Q4
$6.85M Buy
43,501
+249
+0.6% +$36.7K 3.81% 6
2020
Q3
$6.44M Sell
43,252
-136
-0.3% -$20.1K 4.11% 5
2020
Q2
$6.1M Buy
43,388
+501
+1% +$73K 4.21% 6
2020
Q1
$5.62M Buy
42,887
+347
+0.8% +$49.2K 5.01% 4
2019
Q4
$6.21M Buy
42,540
+353
+0.8% +$47.9K 4.48% 5
2019
Q3
$5.46M Buy
42,187
+430
+1% +$56.7K 4.35% 5
2019
Q2
$5.82M Sell
41,757
-3
-0% -$415 4.78% 5
2019
Q1
$5.84M Buy
41,760
+56
+0.1% +$7.5K 4.9% 5
2018
Q4
$5.38M Buy
41,704
+415
+1% +$57.9K 5.14% 4
2018
Q3
$5.71M Buy
41,289
+420
+1% +$55.8K 4.73% 4
2018
Q2
$4.96M Buy
40,869
+1,068
+3% +$133K 4.65% 4
2018
Q1
$5.1M Buy
39,801
+2,467
+7% +$333K 4.85% 4
2017
Q4
$5.22M Buy
+37,334
New +$5.2M 5.11% 4

Other funds holding JNJ

Wells Trecaso Financial Group's JNJ Position: Q3 2025 in Review

Wells Trecaso Financial Group reduced its Johnson & Johnson (JNJ) stake by 42% in Q3 2025, selling an estimated $3.79M and leaving 30,739 shares worth $5.7M. The position accounts for 2.71% of the portfolio, ranked #13.

Wells Trecaso Financial Group first reported a position in JNJ in Q4 2017 and has held it in 32 quarters since. The position peaked at $8.74M in Q1 2025. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Wells Trecaso Financial Group held 30,739 shares of Johnson & Johnson worth $5.7M as of Q3 2025.
  • Wells Trecaso Financial Group sold 22,147 Johnson & Johnson shares in Q3 2025, an estimated $3.79M.
  • Johnson & Johnson made up 2.71% of Wells Trecaso Financial Group's portfolio in Q3 2025, its #13 holding.
  • Wells Trecaso Financial Group first reported a position in Johnson & Johnson in Q4 2017 and has held it in 32 quarters since.
  • Wells Trecaso Financial Group's Johnson & Johnson position peaked at $8.74M in Q1 2025.
  • 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Wells Trecaso Financial Group's 13F filing for Q3 2025, filed 5 Nov 2025.